Testright Nanosystems Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 25-07-2024
- Paid Up Capital ₹ 0.88 M
as on 25-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 25.55%
(FY 2023)
- Profit 277.56%
(FY 2023)
- Ebitda -473.88%
(FY 2023)
- Net Worth 5.47%
(FY 2023)
- Total Assets 11.83%
(FY 2023)
About Testright Nanosystems
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M, as per Ministry of Corporate Affairs (MCA) records.
Shubham Rathore and Jai Rathore serve as directors at the Company.
- CIN/LLPIN
U29271DL2016PTC304635
- Company No.
304635
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Testright Nanosystems Private Limited offer?
Testright Nanosystems Private Limited offers a wide range of products and services, including Testing & Measuring Equipments, Testing Equipment, Diodes & Electronic Active Devices, Diodes, Analyzers & Analytical Instruments, Spectrophotometer, Spectrometer, Sensors & Transducers, Optical Sensors, Surface Coating & Paint Equipment.
Who are the key members and board of directors at Testright Nanosystems?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shubham Rathore | Director | 19-Aug-2016 | Current |
Jai Rathore | Director | 19-Aug-2016 | Current |
Financial Performance of Testright Nanosystems.
Testright Nanosystems Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.55% increase. The company also saw a substantial improvement in profitability, with a 277.56% increase in profit. The company's net worth moved up by a moderate rise of 5.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Testright Nanosystems?
In 2023, Testright Nanosystems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Testright Nanosystems?
Unlock and access historical data on people associated with Testright Nanosystems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Testright Nanosystems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Testright Nanosystems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.